RT Journal Article
SR Electronic
T1 ERS/TSANZ Task Force Statement on the Management of Reproduction and Pregnancy in Women with Airways Diseases
JF European Respiratory Journal
JO Eur Respir J
FD European Respiratory Society
SP 1901208
DO 10.1183/13993003.01208-2019
A1 Peter G. Middleton
A1 Elisabeth J. Gade
A1 Cristina Aguilera
A1 Lucy MacKillop
A1 Brenda M. Button
A1 Courtney Coleman
A1 Barbara Johnson
A1 Charlotte Albrechtsen
A1 Frank Edenborough
A1 David Rigau
A1 Peter G. Gibson
A1 Vibeke Backer
YR 2019
UL http://erj.ersjournals.com/content/early/2019/09/19/13993003.01208-2019.abstract
AB This Statement outlines a review of the literature and expert opinion concerning management of reproduction and pregnancy in women with airways diseases. The Statement represents the first collaboration of the European Respiratory Society (ERS) and the Thoracic Society of Australia and New Zealand (TSANZ) to develop such documents. This Statement covers airways diseases – namely Asthma, Cystic Fibrosis (CF) and non-CF Bronchiectasis. Many women with these diseases are now living into reproductive age with some developing moderate to severe impairment of lung function in early adulthood. The Statement covers aspects of fertility, management during pregnancy, effects of drugs and issues during delivery. The Statement summarises current knowledge but does not make recommendations. This Statement will not discuss the physiological changes occurring in pregnancy, such as the changes in airway physiology, resting ventilation and sleep nor other forms of lung disease such as pulmonary fibrosis, pulmonary hypertension, gastro-oesophageal reflux-related lung disease or issues with nicotine consumption.FootnotesThis manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.Conflict of interest: Dr. Middleton has nothing to disclose.Conflict of interest: Dr. Gade has has nothing to disclose.Conflict of interest: Dr. Aguilera has nothing to disclose.Conflict of interest: Dr. Mackillop reports grants from NIHR Oxford Biomedical Research Centre, personal fees from Sensyne Health plc, outside the submitted work; and was a member of the UK's NICE guideline committee for Intrapartum Care for High Risk Women which included a section on women with asthma..Conflict of interest: Dr. Button has nothing to disclose.Conflict of interest: Courtney ColemanConflict of interest: Barbara JohnsonConflict of interest: Dr. Albrechtsen has nothing to disclose.Conflict of interest: Dr. edenborough has nothing to disclose.Conflict of interest: David RigauConflict of interest: Dr. Gibson reports grants and personal fees from Astrazeneca, Glaxosmithkline, Novartis, Sanofi, outside the submitted work.Conflict of interest: Vibeke Backerno conflict of interest